Zhaoxin Electric Power Technology Co., Ltd. – Trademark Portfolio

Entity Type: 99

Zhaoxin Electric Power Technology Co., Ltd. holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include ARSIMAI. The owner is based in Xiamen.

3E, Unit 431,4/F, Bldg C, Xiamen Int'l

Shipping Center, No.93 Xiangyu Rd

Xiamen 361000 , CN

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

ARSIMAI
ARSIMAI
Registered 2020

Trademark Classifications

Zhaoxin Electric Power Technology Co., Ltd.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

10
Medical Apparatus (1 filing)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does Zhaoxin Electric Power Technology Co., Ltd. have?

Zhaoxin Electric Power Technology Co., Ltd. has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does Zhaoxin Electric Power Technology Co., Ltd. file in?

Zhaoxin Electric Power Technology Co., Ltd. files trademarks across 1 Nice Classification class. The most active classes are Class 10 (Medical Apparatus). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.

What are Zhaoxin Electric Power Technology Co., Ltd.'s most well-known trademarks?

Zhaoxin Electric Power Technology Co., Ltd.'s registered trademark portfolio includes well-known marks such as ARSIMAI. These are among 1 currently registered trademark in the portfolio.

What is Zhaoxin Electric Power Technology Co., Ltd.'s trademark registration success rate?

Zhaoxin Electric Power Technology Co., Ltd. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.